In this sense, the evaluation of LOXL2 levels in serum exosome fractions from head and neck squamous cell carcinoma patients supported the correlation between elevated LOXL2 and low-grade tumours [152]. The gene discussed is LOXL2; the disease is head and neck squamous cell carcinoma.